Ceribell, Inc. (CBLL): Total Liabilities
$40.47M
As of 2025-12-31
$38.03M
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $40.47M | +18.2% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $34.25M | +44.1% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $23.76M | n/a | 2025-02-25, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | 2025-12-31 | $40.47M | +18.2% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $34.00M | -32.8% |
| Electromed, Inc. (ELMD) | 2026-06-30 | $12.29M | +16.0% |
| Outset Medical, Inc. (OM) | 2025-12-31 | $137.54M | -44.8% |
| Iridex Corp (IRIX) | 2026-01-03 | $24.23M | -10.4% |
| Axogen, Inc. (AXGN) | 2025-12-31 | $92.84M | -7.0% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $33.53M | -5.0% |
| electroCore, Inc. (ECOR) | 2025-12-31 | $20.38M | +57.6% |
| InMode Ltd. (INMD) | 2025-12-31 | $83.23M | +1.7% |
Compare CBLL, BLFS, ELMD, OM side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗